Streetbeat News

Regulatory

CI

CVS

HUM

UNH

Cigna and Humana have resumed merger talks after a year-long pause, aiming to consolidate their positions in the health insurance industry amid Medicare cost pressures. This potential merger could significantly impact market dynamics and competition.

Portfolio Pulse from Vandana Singh

October 21, 2024 | 2:27 pm

PGNY

SPY

The Biden-Harris Administration has proposed a rule to expand contraception coverage under the Affordable Care Act, allowing 52 million women to access over-the-counter contraception without cost sharing. This move aims to strengthen reproductive rights and access to contraception amidst ongoing political challenges.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 2:26 pm

SO

Southern Co's Georgia Power has been awarded $160 million by the U.S. Department of Energy to enhance the power grid in Georgia. This funding is aimed at improving the reliability and resilience of the power infrastructure.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 2:20 pm

OKLO

SMR

URA

Taiwan is considering adopting new nuclear technology to meet the increasing electricity demand from chipmakers driven by the AI boom. This marks a potential shift in the government's stance on nuclear power.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:49 pm

LENZ

LENZ Therapeutics shares rose following the FDA's acceptance of its new drug application for LNZ100, aimed at treating Presbyopia.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:44 pm

SPY

The U.S. Supreme Court has declined to hear a Republican-backed challenge to job protections for leaders of the Consumer Product Safety Commission and rejected Michael Cohen's attempt to revive a lawsuit against Donald Trump. This decision maintains the status quo for the Commission's leadership structure and dismisses Cohen's claims related to his imprisonment.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:35 pm

SPY

Federal Reserve's Logan highlights that many healthy banks utilize the discount window when necessary, emphasizing the resilience of the Treasury market as a primary concern for regulators.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:29 pm

SPY

Fed's Logan reports that business contacts are optimistic about the future but remain aware of potential risks. Logan emphasizes the importance of financial conditions indexes in their assessments.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:25 pm

CERO

CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) has submitted a Complete Response Letter to the FDA regarding a clinical hold on its CERO-1236 product. The company has adjusted its clinical entry guidance to early 2025 and disclosed a cash balance of $3.2M as of September 30, 2024.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:05 pm

BMEA

Biomea Fusion has received approval from the World Health Organization for 'Icovamenib' as the international nonproprietary name and USAN designation for its lead candidate BMF-219. This drug is a menin inhibitor aimed at treating diabetes, obesity, and genetically defined cancers.

Portfolio Pulse from Benzinga Newsdesk

October 21, 2024 | 1:02 pm